Zitcare-S 1% Salicylic Acid Gel

Introduction

Zitcare-S is a topical medication that contains Salicylic Acid as its active ingredient. It is available in gel form and is commonly used to treat various skin conditions.

Uses

Zitcare-S is primarily prescribed for the treatment of acne and other dermatological conditions such as psoriasis and calluses. It helps to reduce inflammation and exfoliate the skin, promoting the shedding of dead skin cells and unclogging of pores.

Dosage and Administration

For the best results, follow the instructions provided by your healthcare professional or as indicated on the product label. Generally, Zitcare-S is applied topically to the affected area(s) once or twice daily. Before application, ensure that the skin is clean and dry. Gently massage a thin layer of the gel onto the affected area(s) until it is absorbed. Avoid contact with eyes, mouth, and other mucous membranes.

Mechanism of Action

The active ingredient in Zitcare-S, Salicylic Acid, works by softening and exfoliating the outer layer of the skin. It helps to break down keratin, a protein that forms the structure of the skin, allowing the shedding of dead skin cells. By promoting exfoliation, Salicylic Acid helps to unclog pores and reduce the formation of acne lesions. It also has anti-inflammatory properties that can help reduce redness and swelling associated with acne and other skin conditions.

Side Effects

Common side effects may include skin irritation, redness, dryness, or peeling at the site of application. These side effects are usually mild and temporary. However, if you experience severe skin irritation, rash, swelling, or difficulty breathing after using the gel, seek medical attention immediately.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. While topical medications like Zitcare-S are less likely to interact with other medications compared to oral medications, it is still advisable to exercise caution. There are no known significant drug interactions associated with Zitcare-S.

Precautions

Before using Zitcare-S, inform your healthcare professional if you have any known allergies or sensitivities to Salicylic Acid or any other ingredients in the gel. If you have any open wounds, cuts, or infections on the skin, it is advisable to avoid applying the gel to those areas. Additionally, avoid using the gel on irritated or sunburned skin. Pregnant or breastfeeding women should consult their healthcare professional before using Zitcare-S.

Storage

Patient Tips

• Follow the instructions provided by your healthcare professional or the product label when using Zitcare-S.
• Avoid applying the gel to healthy skin areas or areas not prescribed by your healthcare professional.
• Be patient with the treatment as it may take some time to see noticeable improvements in your skin condition.
• If you experience any persistent or worsening side effects, discontinue use and consult your healthcare professional.
• Protect your skin from excessive sun exposure and use sunscreen when necessary, as Salicylic Acid can increase sensitivity to sunlight.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Isovaleric acidaemia (NHS UK) [Accessed 2 Jun. 2024] (online) Available at:
• Actikerall 5mg/g + 100mg/g Cutaneous Solution (Health Professionals SmPC) Available at:
• Salicylic acid topical (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
• effaclar (salicylic acid) 2 % topical cleanser keratolytics (topical), general (OTC) [Accessed 15 Jun. 2024] (online) Available at:
• Salicylic Acid Topical (MedlinePlus) [Accessed 19 Jun. 2024] (online) Available at:
• Janda T, Szalai G, Pál M. Salicylic Acid Signalling in Plants. Int J Mol Sci. 2020 Apr 10;21(7):2655. doi: 10.3390/ijms21072655. [Accessed 1 Jun. 2024] Available at: